Transgene SA
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Transgene SA
Transgene SA is a biotechnology company that designs and develops targeted immunotherapy products for cancer. Transgene's programs utilize viral vector technology with the goal of indirectly or directly killing infected or cancerous cells. The company's portfolio of products in clinical development includes TG4050, an individualized therapeutic vaccine based on the myvac platform, TG4001, a therapeutic vaccine for HPV positive cancers, as well as BT-001 and TG6050, two oncolytic viruses based on the Invir.IO viral backbone. Transgene has several other programs in clinical and pre-clinical development that are based on its core viral vector technology. Geographically, the majority of its operations are located in France.
/ 
Frequently asked questions
To buy Transgene SA stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Transgene SA by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Transgene SA is TNG:xpar. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Transgene SA has its primary listing on Euronext Paris. You can trade Transgene SA with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Transgene SA is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Transgene SA as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Transgene SA.